APOE and dementia: Compared to the reference group (glucosamine users and APOE ε4 non-carrier), the glucosamine non-users and APOE ε4 carrier group (HR = 2.80, 95% CI: 2.58–3.04) was strongly associated with an increased risk of dementia.